SEARCH RESULT

Total Matching Records found : 762

An American lesson in Court reporting-AG Noorani

For three days in the last week of March, the United States Supreme Court heard arguments on the Affordable Care Act. No Federal law in the U.S. in recent memory has aroused such bitter controversy. If it is struck down as unconstitutional, President Barack Obama's prestige will suffer. He is due for re-election in November. Very many think the court will rule against him in June. The core of the law...

More »

Supreme Court asks Centre to submit endosulfan disposal plan-Savvy Soumya Misra

The Supreme Court has asked the Centre to submit a disposal plan for the raw material used to manufacture endosulfan, Hexachlorocyclopentadiene (HCCP), an organochlorine compound. It is used in several pesticides. The Supreme Court had given an interim order  to ban the use, manufacture, sale and export of endosulfan on May 13 last year. Exports were allowed in September and December last year. The April 23 order came after the Pesticides...

More »

Wal-Mart in bribe scandal

-The Telegraph   The New York Times has reported that Wal-Mart, the US-based retail giant, hushed up an internal investigation sometime after the company was told of a bribery campaign to obtain licences and facilitate rapid expansion in Mexico. Some of the alleged instances of bribery are certain to ring a bell in India where it is not too difficult to bend rules for a price. The New York Times said its “examination...

More »

Western warnings-R Ramachandran

India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...

More »

Patent to plunder -Amit Sengupta

India's efforts to produce and supply life-saving drugs at affordable prices face challenges from multinational companies trying to “evergreen” their patents. THE average life expectancy across the globe has increased from around 30 years a century ago to over 65 years today. This has been made possible in large part by modern medicine. Never before in history have humans had access to such an array of medicines and devices to...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close